Patients benefit from antiplatelet therapy after coronary-artery bypass grafting (CABG) for an acute coronary syndrome. Whether the addition of ticagrelor to aspirin, as compared with aspirin alone, ...
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. Novo Nordisk has decided to stop its phase 3 kidney outcomes trial evaluating semaglutide in adults with type 2 diabetes and chronic ...
Improvements in medical therapy, carotid-artery stenting, and carotid endarterectomy call into question the preferred management of asymptomatic carotid stenosis. Whether adding revascularization to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results